Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population

Frequency of common CYP3A5 gene variants in healthy Polish newborn infants

(2014) Grażyna Adler et al.   Pharmacological Reports

C3435T Polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish population

(2014) Michał Dudarewicz et al.   Pharmacological Reports

Distribution of CYP2D6 and CYP2C19 Polymorphisms Associated with Poor Metabolizer Phenotype in Five Amerindian Groups and Western Mestizos from Mexico

(2012) Joel Salazar-Flores et al.   Genetic Testing and Molecular Biomarkers

Association ofCYP2C19*2and*3Genetic Variants with Essential Hypertension in Koreans

(2012) Dong-Jik Shin et al.   YONSEI MEDICAL JOURNAL

CYP2C19 and ABCB1gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population

(2011) Paulo CJL Santos et al.   BMC Medical Genetics

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

(2011) Joanne S. L. Lim et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development

(2011) Kouichi Kurose et al.   Drug Metabolism and Pharmacokinetics

Genetic variants inCYP(-1A2,-2C9,-2C19,-3A4and-3A5),VKORC1andABCB1genes in a black South African population: a window into diversity

(2011) Collet Dandara et al.   PHARMACOGENOMICS

Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregation

(2011) Su-Jun Lee et al.   THROMBOSIS RESEARCH

Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis

(2011) Yan Ping Liu et al.   THROMBOSIS RESEARCH

CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention

(2011) George Kassimis et al.   THROMBOSIS RESEARCH

Frequencies of CYP3A5 genotypes and haplotypes in a Korean population

(2010) S. Y. Park et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations

(2009) Kyle J Ellis et al.   PHARMACOGENOMICS

Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance

(2008) Laurent Bonello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents

(2008) Dietmar Trenk et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19⁎2 allele on clopidogrel responsiveness

(2007) Pierre Fontana et al.   THROMBOSIS RESEARCH